Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Bioorg Med Chem. 2019 Jun 4;27(15):3254–3278. doi: 10.1016/j.bmc.2019.06.003

Scheme 10.

Scheme 10.

Methods used for the preparation of 18. Reagents and conditions a) 2-phenethyl-4-phenylbutanoic acid, EDC, HOBT, 2,6-lutidine; b) TFA, CH2Cl2; c) 1,3-diboc-2-(trifluoromethylsulfonyl)guanidine, Et3N, DCM (29%); d) TFA, DCM (100%)